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Here we address the issue of the possible interplay
between host genetic variation and the risk of acquiring
Plasmodium falciparum drug-resistant strains. The invol-
vement of human genetic variation as a possible co-factor
in the selection and spread of P. falciparum drug resis-
tance is a new tool in the study of malaria and possibly of
other infectious diseases. The driving hypothesis of this
approach is that parasite drug resistance could be affected
both by ethnicity and human variability in the genes
encoding for enzymes that metabolise antimalarials (cyto-
chrome P450 liver enzymes). Understanding if parasite
drug sensitivity is influenced and possibly modulated by
human diversity can contribute to a better knowledge and
control of the spread of drug resistance. So far, few studies
have addressed this strategic issue. To explore this hypoth-
esis we carried out an association analysis on 506 human/
P. falciparum DNA samples from adult asymptomatic
subjects belonging to three sympatric ethnic groups of
Burkina Faso, an area of hyperendemic malaria in West
Africa. Here we report that the prevalence of chloroquine-
resistant infections (pfcrt 76T and/or pfmdr1 86Y) differs
among sympatric ethnic groups, being higher in Mossi
and Rimaibé compared to Fulani (OR: 2.24; 1.27-3.92; P =
0.007). Moreover, the human CYP2C8*2 variant, known to
determine a poor drug metaboliser phenotype, is asso-
ciated with P. falciparum chloroquine-resistant infections
(OR: 1.66; 1.13-2.43; P = 0.008). The results strongly sug-
gest that human genetic variation affects the dynamics of
selection of parasite drug-resistance. We strongly believe
that these observations are of general interest and may
have important implications in public health.
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